戻る Agenda
Session1:Establishing a Mature Ecosystem for New Modalities ~ Lessons Learned from Success Cases~ [Panel Discussion]
Session Chair(s)
Sumimasa Nagai, MD, PhD
Institute for Advancement of Clinical and Translational Science(iACT), Kyoto University Hospital, Japan
Akihiro Kume
Advisor, Corporate Planning Office, BREXA Advan Inc., Japan
Speaker(s)
Kuboniwa Hitoshi
CEO, Renzoku Biologics Co., Ltd, Japan
Hakui Hideyuki
Office for Regenerative Medicine Research Promotion, Research and Development Di, Ministry of Health, Labour and Welfare, Japan
Haga Megumi
Department of Research and Development Strategy, Japan Agency for Medical Research and Development, Japan
Kenji Nonaka, MD, PhD
President, Representative Director and CEO, Orizuru Therapeutics, Inc, Japan
Hisashi Mitsuguchi
Senior Investment Director, DBJ Capital Co., Ltd., Japan